Keyword: Biotechnology

News

Bristol-Myers Squibb to Buy Padlock

24.03.2016 - US drugmaker Bristol-Myers Squibb (BMS) has signed an agreement to acquire Padlock Therapeutics, a privately owned biotechnology firm based at Cambridge, Massachusetts, which...

News

GSK and Miltenyi Biotec in Cell and Gene Therapy Pact

22.03.2016 - Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...

News

Blueprint and Roche in Cancer Immunotherapy Deal

17.03.2016 - US biotechnology company Blueprint Medicines is collaborating with Swiss drugs giant Roche on the discovery, development and commercialization of up to five cancer immunotherapies...

News

GSK Ends Cancer Deal With Five Prime

15.03.2016 - British drugmaker Glaxo SmithKline (GSK) has pulled out of a five-year deal with US biotechnology company Five Prime to develop experimental cancer drug FP-1039. Buried in Five...

News

Patheon and Amgen in Toll Manufacturing Pact

15.03.2016 - US contract drug development and manufacturing services provider Patheon has signed a toll production agreement with leading biotechnology company Amgen. The US firms are based at...

News

Sanofi Seals two Oncology Partnerships

14.01.2016 - French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...

News

Industrial Biotech Firm Brain Plans IPO

07.01.2016 - In one of the rare stock launches of a German biotechnology company, industrial biotech firm Brain has announced plans to raise a double-digit sum through an initial public...

News

AstraZeneca Confirms Talks with Acerta

15.12.2015 - AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...